KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Asset Writedowns and Impairment (2016 - 2025)

Pfizer (PFE) has disclosed Asset Writedowns and Impairment for 17 consecutive years, with $4.3 billion as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A to $4.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $4.9 billion for FY2025, 15.51% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $4.3 billion at Pfizer, up from $260.0 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $5.9 billion in Q4 2023, with the low at $24.0 million in Q2 2021.
  • Average Asset Writedowns and Impairment over 5 years is $977.8 million, with a median of $212.0 million recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment soared 751.61% in 2023, then tumbled 61.25% in 2025.
  • Over 5 years, Asset Writedowns and Impairment stood at $31.0 million in 2021, then skyrocketed by 545.16% to $200.0 million in 2022, then surged by 2867.5% to $5.9 billion in 2023, then crashed by 95.96% to $240.0 million in 2024, then skyrocketed by 1701.25% to $4.3 billion in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $4.3 billion, $260.0 million, and $93.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.